With higher raspberry intake, individuals at risk for diabetes needed less insulin to manage blood glucose

Sustained increase in physical activity, decrease in sedentary time seen with behavioral intervention

'Authorized generic' of Humalog 100 to sell for $137.35 per vial, 50 percent lower than list price

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Risk Factors …

Mean decrease in HbA1c greater than that seen with health care professional support only

Time spent self-monitoring required for weight loss diminishes over time

Revascularization patients with T2DM and CKD more likely to experience a major adverse event

Achievement rates for all three targets and for HbA1c, BP, LDL-C are lowest in the winter

Findings show weight loss from intervention regardless of an individual's diabetes status

Ultrasound readings of left or right foot can predict good versus poor bone quality